Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Danaher Corp. (GB:0R2B)
LSE:0R2B
Danaher (0R2B) Share Price & Analysis
1 Followers
0R2B Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$181.78 - $258.25
Previous Close$247.35
Volume723.00
Average Volume (3M)22.50K
Market Cap
$182.64B
Enterprise Value$200.81B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$18.16B
Price to Earnings (P/E)41.9
Beta1.03
Next Earnings
Jul 18, 2024EPS Estimate
$1.59Last Dividend Ex-Date
Mar 27, 2024Dividend Yield0.43%
Share Statistics
EPS (TTM)5.90
Shares Outstanding740,686,541
10 Day Avg. Volume16,937
30 Day Avg. Volume22,502
Standard Deviation0.06
R-Squared0.09
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-25.05
Price to Sales (P/S)30.64
Price to Cash Flow (P/CF)26.30
P/FCF Ratio30.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.92
Enterprise Value/Gross Profit14.31
Enterprise Value/Ebitda28.57
Forecast
1Y Price Target
$277.64Price Target Upside12.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Danaher News
PremiumStock Analysis & Ideas
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?
Bulls Say, Bears Say
Bulls Say
Company PerformanceRevenue exceeded expectations, primarily due to a strong performance in the Biotech segment.
Financial OutlookAnalyst recommends DHR as the leader in the bioprocess tools market with a diversified portfolio in Life Science Tools and Diagnostics.
Market LeadershipThe company is recognized as a sector leader with a strong bioprocessing franchise.
Bears Say
Bioprocessing Sector OutlookVisibility in Bioprocessing remains limited with continued destocking in 1H24, and gradual improvement expected as year progresses.
Currency Exchange ImpactForeign exchange rates turned negative for DHR, now presenting a 1% headwind to FY revenues.
Geographic Revenue DeclineChina region sales declined significantly, including a 40% decrease in the Biotechnology segment.
---
Options Prices
Currently, No data available
---
Ownership Overview
9.18% Insiders
27.64% Mutual Funds
18.57% Other Institutional Investors
44.62% Public Companies and
Individual Investors
0R2B FAQ
What was Danaher Corp.’s price range in the past 12 months?
Danaher Corp. lowest share price was $181.78 and its highest was $258.25 in the past 12 months.
What is Danaher Corp.’s market cap?
Currently, no data Available
When is Danaher Corp.’s upcoming earnings report date?
Danaher Corp.’s upcoming earnings report date is Jul 18, 2024 which is in 80 days.
How were Danaher Corp.’s earnings last quarter?
Danaher Corp. released its earnings results on Apr 23, 2024. The company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.717 by $0.203.
Is Danaher Corp. overvalued?
According to Wall Street analysts Danaher Corp.’s price is currently Undervalued.
Does Danaher Corp. pay dividends?
Danaher Corp. pays a Quarterly dividend of $0.27 which represents an annual dividend yield of 0.43%. See more information on Danaher Corp. dividends here
What is Danaher Corp.’s EPS estimate?
Danaher Corp.’s EPS estimate is $1.59.
How many shares outstanding does Danaher Corp. have?
Danaher Corp. has 740,686,500 shares outstanding.
What happened to Danaher Corp.’s price movement after its last earnings report?
Danaher Corp. reported an EPS of $1.92 in its last earnings report, beating expectations of $1.717. Following the earnings report the stock price went up 6.614%.
Which hedge fund is a major shareholder of Danaher Corp.?
Among the largest hedge funds holding Danaher Corp.’s share is Fisher Asset Management LLC. It holds Danaher Corp.’s shares valued at 978M.
---
Danaher Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$277.64 (12.25% Upside)
$277.64 (12.25% Upside)
Blogger Sentiment
Bullish
GB:0R2B Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $14.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
20.20%
12-Months-Change
Fundamentals
Return on Equity
8.47%
Trailing 12-Months
Asset Growth
-1.93%
Trailing 12-Months
Company Description
Danaher Corp.
Founded in 1969 and headquartered in Washington, DC, Danaher Corp. engages in manufacturing, designing and marketing of professional, medical, industrial and commercial products and services. The company operates through three segments, including Life Sciences, Diagnostics, and Environmental & Applied Solutions.
---
0R2B Company Deck
---
0R2B Earnings Call
Q1 2024
0:00 / 0:00
---
0R2B Revenue Breakdown
40.09% Diagnostics
30.02% Biotechnology
29.89% Life Sciences
---
0R2B Stock 12 Months Forecast
Average Price Target
$277.64
▲(12.25% Upside)
Technical Analysis
Best Analysts Covering 0R2B
1 Year
1 Year Success Rate
24/29 ratings generated profit
1 Year Average Return
+12.85%
reiterated a buy rating 3 months ago
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 82.76% of your transactions generating a profit, with an average return of +12.85% per trade.
---